With the analysis among 23,020 patents, we discovered top 470 key players by total patent application. F. Hoffmann-La Roche Ltd., Novartis AG, Genentech, Inc. are dominant in this area. They take 10.06% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 700
California, United States
Patent: 501
New York, United States
Patent: 498
Indiana, United States
Patent: 386
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 328
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 326
California, United States
Patent: 305
Hessen, Germany
Patent: 285
New Jersey, United States
Patent: 272
With the analysis among 611 patents, we discovered top 122 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Synthorx, Inc., Primevax Immuno-Oncology, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 28
Primevax Immuno-Oncology, Inc.
California, United States
Patent: 23
ZURICH, Switzerland
Patent: 19
California, United States
Patent: 18
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 13
Massachusetts, United States
Patent: 12
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Bayern, Germany
Patent: 12
Oncxerna Therapeutics, Inc.
Massachusetts, United States
Patent: 12
With the analysis among related 8,252 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Novartis AG, F. Hoffmann-La Roche Ltd., Pfizer Inc. take 7.42% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 267
F. Hoffmann-La Roche Ltd.
New York, United States
Patent: 141
New York, United States
Patent: 130
California, United States
Patent: 127
California, United States
Patent: 107
Cambridgeshire, United Kingdom
Patent: 102
New Jersey, United States
Patent: 97
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 94
Delaware, United States
Patent: 93
With the analysis among related 8,252 patents in last 5 years, we discover 252 new entrants. Fate Therapeutics, Inc., ADC Therapeutics SA, 4D Pharma Research Ltd. are the most active new entrants in this area.
California, United States
Patent: 107
Vaud, Switzerland
Patent: 76
Aberdeen City, United Kingdom
Patent: 61
Mirati Therapeutics, Inc.
California, United States
Patent: 55
Texas, United States
Patent: 47
Massachusetts, United States
Patent: 43
Fusion Pharmaceuticals, Inc.
Ontario, Canada
Patent: 38
Alkermes Pharma Ireland Ltd.
Turning Point Therapeutics, Inc.
California, United States
Patent: 36
With the analysis among 3,181 patents, we discovered top 239 universities and scientific research institutions by total patent application. The European Molecular Biology Laboratory, The Johns Hopkins University, Icahn School of Medicine at Mount Sinai are dominant in this area. They take 15.06% of the total patent filing.
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 115
The Johns Hopkins University
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 65
University of South Florida
North Carolina, United States
Patent: 54
President & Fellows of Harvard College
Massachusetts, United States
Patent: 41
ZURICH, Switzerland
Patent: 34
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 29
University of Cincinnati Physicians Co. LLC
Ohio, United States
Patent: 27